Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Moderna Revenue 2017-2019 | MRNA

Moderna annual/quarterly revenue history and growth rate from 2017 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Moderna revenue for the quarter ending December 31, 2019 was $0.014B, a 60.32% decline year-over-year.
  • Moderna revenue for the twelve months ending December 31, 2019 was $0.060B, a 55.42% decline year-over-year.
  • Moderna annual revenue for 2019 was $0.06B, a 55.42% decline from 2018.
  • Moderna annual revenue for 2018 was $0.135B, a 34.38% decline from 2017.
  • Moderna annual revenue for 2017 was $0.206B, a 89.88% increase from 2016.
  
Moderna Annual Revenue
(Millions of US $)
2019 $60
2018 $135
2017 $206
2016 $108
Moderna Quarterly Revenue
(Millions of US $)
2019-12-31 $14
2019-09-30 $17
2019-06-30 $13
2019-03-31 $16
2018-12-31 $35
2018-09-30 $42
2018-06-30 $29
2018-03-31 $29
2017-12-31
2016-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $11.397B $0.060B
Moderna Inc. is a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines for patients. The company's product pipeline which is in clinical stage consists of mRNA-1647 for Cytomegalovirus Infectious Disease, mRNA-4157 for Solid tumors, mRNA-2416 for lymphoma and mRNA- 2752 for Relapsed/Refractory solid tumors malignancies. Moderna Inc. is based in Cambridge, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $124.791B 14.27
Gilead Sciences (GILD) United States $97.863B 12.66
CSL (CSLLY) Australia $90.292B 0.00
Vertex Pharmaceuticals (VRTX) United States $66.191B 60.07
Regeneron Pharmaceuticals (REGN) United States $55.479B 23.50
Biogen (BIIB) United States $54.202B 9.26
Illumina (ILMN) United States $40.867B 42.25
Seattle Genetics (SGEN) United States $21.467B 0.00
Alexion Pharmaceuticals (ALXN) United States $21.302B 9.88
Incyte (INCY) United States $18.450B 39.59
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.127B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.892B 636.69
Genmab (GMAB) Denmark $14.017B 10.88
Galapagos (GLPG) Belgium $13.121B 40.10
Genmab (GNMSF) Denmark $13.109B 42.16
Alnylam Pharmaceuticals (ALNY) United States $12.680B 0.00
BioNTech SE (BNTX) Germany $11.931B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.292B 52.78
BeiGene (BGNE) Cayman Islands $9.396B 0.00
Exact Sciences (EXAS) United States $9.214B 0.00
QIAGEN (QGEN) Netherlands $9.110B 27.78
Sarepta Therapeutics (SRPT) United States $7.861B 0.00
Bio-Techne Corp (TECH) United States $7.461B 51.06
ACADIA Pharmaceuticals (ACAD) United States $6.725B 0.00
Guardant Health (GH) United States $6.323B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.077B 16.06
ARGENX SE-ADR (ARGX) Netherlands $5.853B 0.00
Ascendis Pharma (ASND) Denmark $5.649B 0.00
Exelixis (EXEL) United States $5.396B 17.32
Repligen (RGEN) United States $5.245B 95.91
Acceleron Pharma (XLRN) United States $4.652B 0.00
Reata Pharmaceuticals (RETA) United States $4.595B 0.00
Vir Biotechnology (VIR) United States $4.030B 0.00
Immunomedics (IMMU) United States $4.018B 0.00
China Biologic Products (CBPO) China $3.903B 23.17
Adaptive Biotechnologies (ADPT) United States $3.550B 0.00
Blueprint Medicines (BPMC) United States $3.546B 0.00
Global Blood Therapeutics (GBT) United States $3.492B 0.00
Mirati Therapeutics (MRTX) United States $3.433B 0.00
MorphoSys AG (MOR) Germany $3.340B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.284B 0.00
Emergent Biosolutions (EBS) United States $3.190B 22.14
Zai Lab (ZLAB) China $3.047B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.979B 0.00
NeoGenomics (NEO) United States $2.747B 119.09
CRISPR Therapeutics AG (CRSP) Switzerland $2.568B 43.47
Amicus Therapeutics (FOLD) United States $2.531B 0.00
Bluebird Bio (BLUE) United States $2.411B 0.00
Alkermes (ALKS) Ireland $2.390B 189.38
Halozyme Therapeutics (HALO) United States $2.383B 0.00
Arena Pharmaceuticals (ARNA) United States $2.379B 6.20
Deciphera Pharmaceuticals (DCPH) United States $2.350B 0.00
MyoKardia (MYOK) United States $2.238B 0.00
UniQure (QURE) Netherlands $2.116B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.065B 0.00
Denali Therapeutics (DNLI) United States $1.976B 0.00
Principia Biopharma (PRNB) United States $1.914B 0.00
Fate Therapeutics (FATE) United States $1.883B 0.00
Alector (ALEC) United States $1.840B 0.00
Amarin (AMRN) Ireland $1.715B 0.00
Eidos Therapeutics (EIDX) United States $1.690B 0.00
Arvinas (ARVN) United States $1.664B 0.00
Zymeworks (ZYME) Canada $1.646B 0.00
Insmed (INSM) United States $1.597B 0.00
Akcea Therapeutics (AKCA) United States $1.592B 34.24
Viela Bio (VIE) United States $1.556B 0.00
Epizyme (EPZM) United States $1.540B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.461B 0.00
Ligand Pharmaceuticals (LGND) United States $1.278B 39.71
Inovio Pharmaceuticals (INO) United States $1.230B 0.00
Zealand Pharma (ZEAL) Denmark $1.187B 0.00
Editas Medicine (EDIT) United States $1.172B 0.00
Myriad Genetics (MYGN) United States $1.142B 20.16
Coherus BioSciences (CHRS) United States $1.126B 13.40
REGENXBIO (RGNX) United States $1.117B 0.00
PHARMA MAR SA (PHMMF) Spain $1.107B 0.00
Twist Bioscience (TWST) United States $1.054B 0.00
NextCure (NXTC) United States $1.032B 0.00
NGM Biopharmaceuticals (NGM) United States $0.908B 0.00
Revance Therapeutics (RVNC) United States $0.887B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Intra-Cellular Therapies (ITCI) United States $0.858B 0.00
Beam Therapeutics (BEAM) United States $0.855B 0.00
Novavax (NVAX) United States $0.830B 0.00
Adverum Biotechnologies (ADVM) United States $0.794B 0.00
I-Mab (IMAB) China $0.787B 0.00
Sangamo Therapeutics (SGMO) United States $0.787B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.756B 0.00
Cytokineticsorporated (CYTK) United States $0.741B 0.00
Arcus Biosciences (RCUS) United States $0.717B 0.00
Retrophin (RTRX) United States $0.694B 0.00
Bellus Health (BLU) Canada $0.671B 0.00
Athenex (ATNX) United States $0.664B 0.00
Pharming Group (PHGUF) Netherlands $0.663B 0.00
Mesoblast (MESO) Australia $0.662B 0.00
GENFIT S.A (GNFT) France $0.661B 0.00
Cara Therapeutics (CARA) United States $0.626B 0.00
Kadmon Holdings (KDMN) United States $0.622B 0.00
Intellia Therapeutics (NTLA) United States $0.621B 0.00
Codexis (CDXS) United States $0.616B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.589B 5.18
Compugen (CGEN) Israel $0.556B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.556B 0.00
ANI Pharmaceuticals (ANIP) United States $0.523B 9.44
Castle Biosciences (CSTL) United States $0.519B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.513B 0.00
Intrexon (PGEN) United States $0.504B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.500B 0.00
Clovis Oncology (CLVS) United States $0.499B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.497B 0.00
MeiraGTx Holdings (MGTX) United States $0.497B 0.00
AC Immune SA (ACIU) Switzerland $0.489B 12.48
Frequency Therapeutics (FREQ) United States $0.487B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.484B 0.00
Prothena (PRTA) Ireland $0.474B 0.00
Sorrento Therapeutics (SRNE) United States $0.473B 0.00
Athersys (ATHX) United States $0.463B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Morphic Holding (MORF) United States $0.457B 0.00
Heska (HSKA) United States $0.439B 0.00
Scholar Rock Holding (SRRK) United States $0.432B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.424B 0.00
Verastem (VSTM) United States $0.420B 0.00
UROGEN PHARMA (URGN) United States $0.419B 0.00
AnaptysBio (ANAB) United States $0.416B 0.00
Vericel (VCEL) United States $0.414B 61.33
DBV Technologies S.A (DBVT) France $0.413B 0.00
Anika Therapeutics (ANIK) United States $0.412B 14.19
Cel-Sci (CVM) United States $0.409B 0.00
Agenus (AGEN) United States $0.399B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.390B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.382B 0.00
BioDelivery Sciences (BDSI) United States $0.381B 43.89
Cue Biopharma (CUE) United States $0.381B 0.00
MiMedx (MDXG) United States $0.378B 0.00
Cellectis S.A (CLLS) France $0.376B 0.00
CytomX Therapeutics (CTMX) United States $0.364B 0.00
PDL BioPharma (PDLI) United States $0.351B 10.52
Kala Pharmaceuticals (KALA) United States $0.342B 0.00
Merus (MRUS) Netherlands $0.334B 0.00
Pfenex (PFNX) United States $0.306B 446.50
Syndax Pharmaceuticals (SNDX) United States $0.302B 0.00
Puma Biotechnology (PBYI) United States $0.300B 0.00
Syros Pharmaceuticals (SYRS) United States $0.299B 0.00
Cellular Biomedicine (CBMG) United States $0.299B 0.00
NantKwest (NK) United States $0.295B 0.00
Precision BioSciences (DTIL) United States $0.292B 0.00
WAVE Life Sciences (WVE) Singapore $0.289B 0.00
Dynavax Technologies (DVAX) United States $0.280B 0.00
ADMA Biologics Inc (ADMA) United States $0.275B 0.00
Avid Bioservices (CDMO) United States $0.271B 0.00
Kamada (KMDA) Israel $0.269B 11.20
Autolus Therapeutics (AUTL) United Kingdom $0.255B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.250B 0.00
Gritstone Oncology (GRTS) United States $0.246B 0.00
Mersana Therapeutics (MRSN) United States $0.244B 0.00
Stemline Therapeutics (STML) United States $0.240B 0.00
Albireo Pharma (ALBO) United States $0.238B 0.00
Seres Therapeutics (MCRB) United States $0.236B 0.00
Aduro Biotech (ADRO) United States $0.232B 0.00
Sutro Biopharma (STRO) United States $0.229B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.229B 0.00
Geron (GERN) United States $0.224B 0.00
ChromaDex (CDXC) United States $0.209B 0.00
MannKind (MNKD) United States $0.209B 0.00
Starpharma Holdings (SPHRY) Australia $0.201B 0.00
Alcobra (ARCT) United States $0.200B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.199B 1.79
XOMA (XOMA) United States $0.197B 0.00
Abeona Therapeutics (ABEO) United States $0.191B 0.00
Prometic Life Sciences (LMNL) Canada $0.184B 0.00
Protagonist Therapeutics (PTGX) United States $0.183B 0.00
HOOKIPA Pharma (HOOK) United States $0.181B 0.00
VBI Vaccines (VBIV) United States $0.178B 0.00
IVERIC Bio (ISEE) United States $0.170B 0.00
Selecta Biosciences (SELB) United States $0.169B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.163B 0.00
Spero Therapeutics (SPRO) United States $0.162B 0.00
OSMOTICA PHARM (OSMT) United States $0.161B 0.00
Kindred Biosciences (KIN) United States $0.160B 0.00
Liquidia Technologies (LQDA) United States $0.159B 0.00
Fortress Biotech (FBIO) United States $0.157B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.152B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Dyadic (DYAI) United States $0.144B 0.00
Aytu Bioscience (AYTU) United States $0.143B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.141B 0.00
Affimed (AFMD) Germany $0.139B 0.00
VolitionRX (VNRX) United States $0.138B 0.00
Windtree Therapeutics (WINT) United States $0.136B 0.00
Cerecor (CERC) United States $0.135B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Biofrontera AG (BFRA) Germany $0.133B 0.00
Theratechnologies (THTX) Canada $0.129B 0.00
Antibe Therapeutics (ATBPF) Canada $0.127B 0.00
Exicure (XCUR) United States $0.123B 0.00
AIT Therapeutics (XAIR) United States $0.122B 0.00
VTv Therapeutics (VTVT) United States $0.121B 0.00
Enzo Biochem (ENZ) United States $0.120B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.118B 4.64
Northwest Biotherapeutics (NWBO) United States $0.105B 0.00
Strongbridge Biopharma (SBBP) United States $0.105B 0.00
Celyad SA (CYAD) Belgium $0.103B 0.00
Palatin Technologies (PTN) United States $0.100B 2.73
Cidara Therapeutics (CDTX) United States $0.099B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.098B 0.00
Aptinyx (APTX) United States $0.098B 0.00
TELA Bio (TELA) United States $0.091B 0.00
ARAVIVE, INC (ARAV) United States $0.089B 0.00
IBio (IBIO) United States $0.089B 0.00
CorMedix Inc (CRMD) United States $0.088B 0.00
PHASEBIO PHARMA (PHAS) United States $0.086B 0.00
Five Prime Therapeutics (FPRX) United States $0.086B 0.00
Happiness Biotech Group (HAPP) China $0.085B 0.00
Arbutus Biopharma (ABUS) Canada $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.072B 0.00
Cyclerion Therapeutics (CYCN) United States $0.071B 0.00
Clearside Biomedical (CLSD) United States $0.070B 0.00
Orgenesis (ORGS) United States $0.070B 4.11
Checkpoint Therapeutics (CKPT) United States $0.068B 0.00
Adocia (ADOCY) France $0.066B 0.00
Eton Pharmaceuticals (ETON) United States $0.065B 0.00
Vaccinex (VCNX) United States $0.063B 0.00
Applied Genetic Technologies (AGTC) United States $0.061B 0.00
Emmaus Life Sciences (EMMA) United States $0.061B 0.00
Proteostasis Therapeutics (PTI) United States $0.060B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
SESEN BIO, INC (SESN) United States $0.059B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.057B 0.00
Synlogic (SYBX) United States $0.057B 0.00
AquaBounty Technologies (AQB) United States $0.054B 0.00
Catalyst Biosciences (CBIO) United States $0.052B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.050B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.050B 0.00
Trevena (TRVN) United States $0.048B 0.00
Stealth BioTherapeutics (MITO) United States $0.047B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
Acorda Therapeutics (ACOR) United States $0.045B 0.00
Idera Pharmaceuticals (IDRA) United States $0.039B 0.00
Organovo Holdings (ONVO) United States $0.039B 0.00
Cocrystal Pharma (COCP) United States $0.038B 0.00
Advaxis (ADXS) United States $0.038B 0.00
Soligenix (SNGX) United States $0.037B 0.00
Lumos Pharma (LUMO) United States $0.037B 0.00
AmpliPhi Biosciences (ARMP) United States $0.036B 0.00
Protalix BioTherapeutics (PLX) Israel $0.035B 0.00
Menlo Therapeutics (MNLO) United States $0.034B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.034B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
CollPlant Holdings (CLGN) Israel $0.033B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.033B 0.00
Celldex Therapeutics (CLDX) United States $0.031B 0.00
Prima BioMed (IMMP) Australia $0.027B 0.00
Pulmatrix (PULM) United States $0.027B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.027B 0.00
OvaScience (MLND) United States $0.026B 0.00
Celsion (CLSN) United States $0.026B 0.00
Evogene (EVGN) Israel $0.025B 0.00
ATyr Pharma (LIFE) United States $0.025B 0.00
TOCAGEN INC (TOCA) United States $0.025B 0.00
Curis (CRIS) United States $0.024B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Signal Genetics (MGEN) United States $0.021B 0.00
BioCardia (BCDA) United States $0.020B 0.00
Entera Bio (ENTX) Israel $0.020B 0.00
Alimera Sciences (ALIM) United States $0.019B 0.00
Novogen (KZIA) Australia $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.018B 0.00
Stellar Biotechnologies (EDSA) Canada $0.018B 0.00
AEterna Zentaris (AEZS) United States $0.017B 0.00
Oncobiologics (OTLK) United States $0.017B 0.00
Apricus Biosciences (SEEL) United States $0.017B 0.00
Cesca Therapeutics (THMO) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
VIVUS (VVUS) United States $0.014B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
Aptevo Therapeutics (APVO) United States $0.011B 0.00
Unum Therapeutics (UMRX) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
TrovaGene (TROV) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
IMMURON (IMRN) Australia $0.006B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00